Enalapril (10 mg/day) in systemic sclerosis: One year, double blind, randomised study (ESS-1): Pulmonary substudy - Effects of three month treatment

Advances in Experimental Medicine and Biology

Volumn 455, Issue , 1999, Pages 289-293

  Ostrowski, S ^a   Chibowska, M ^a   Bilan, A ^a   Palusinski R ^a   Weglarz J ^a   Makaruk, B ^a   Krasowska, D ^a   Hanzlik, J ^a  

^a NONE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PLACEBO;

ADULT; AIRWAY RESISTANCE; BODY PLETHYSMOGRAPHY; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LUNG FUNCTION TEST; LUNG VOLUME; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME;

EID: 0033282343     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4857-7_42     Document Type: Conference Paper

References (14)

1. Serial changes in scleroderma and idiopathic interstitial lung disease
2. Survival with systemic asclerosis (scleroderma) A life table analysis of clinical and demographic factors in 309 patients
3. Heart disease in systemic Sclerosis
4. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
5. Volumes pulmonaires et debits ventilatoires forces. Groupe de travail sur la standardisation des epreuves fonctionnelles respiratoires. Communaute Europeenne du Charbon et de l'Acier
6. Die Lungfunction
7. Interstitial lung disease of systemic sclerosis
8. Lung involvement in systemic sclerosis (scleroderma): Relation to classification based on extent of skin involvement or autoantibody status
9. A longitudinal study of pulmonary function in Danish patients with systemic sclerosis
10. Serial pulmonary Function in Systemic Sclerosis
11. Pulmonary function in scleroderma
12. Pulmonary function in patients with systemic sclerosis
13. Antihypertensive drugs and airway function, with special reference to calcium channel blockade
14. Regression of chronic hypoxia-induced pulmonary hypertension, right ventricular hypertrophy, and fibrosis: Effect of enalapril